These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 278471)

  • 1. The absorption of insulin.
    Schlichtkrull J
    Acta Paediatr Scand Suppl; 1977; (270):97-102. PubMed ID: 278471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
    Berger M; Cüppers HJ; Hegner H; Jörgens V; Berchtold P
    Diabetes Care; 1982; 5(2):77-91. PubMed ID: 6765510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J
    BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S; Vaag A; Langkjaer L; Hougaard P; Markussen J
    BMJ; 1989 Aug; 299(6696):415-9. PubMed ID: 2506998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 125I used for labelling of proteins in an absorption model changes the absorption rate of insulin aspart.
    Sohoel A; Plum A; Frokjaer S; Thygesen P
    Int J Pharm; 2007 Feb; 330(1-2):114-20. PubMed ID: 17070660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.
    Fischer U; Freyse EJ; Jutzi E; Besch W; Raschke M; Höfer S; Albrecht G
    Diabetologia; 1983 Mar; 24(3):196-201. PubMed ID: 6341148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin antibodies, insulin dose, and diabetic control.
    Walford S
    Lancet; 1983 Feb; 1(8321):410-1. PubMed ID: 6130394
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs.
    Deckert T; Hansen B; Kølendorf K; Poulsen JS; Smith M
    Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):30-7. PubMed ID: 6751023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.
    Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R
    Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin.
    de Meijer PH; Lutterman JA; van't Laar A
    Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of insulin following intravenous and subcutaneous administration in canines.
    Ravis WR; Comerci C; Ganjam VK
    Biopharm Drug Dispos; 1986; 7(5):407-20. PubMed ID: 3535917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of circulating epinephrine on absorption of subcutaneously injected insulin.
    Fernqvist E; Gunnarsson R; Linde B
    Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring.
    Molnar GD; Taylor WF; Langworthy AL
    Mayo Clin Proc; 1972 Oct; 47(10):709-19. PubMed ID: 4635563
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.
    Gray RS; Cowan P; di Mario U; Elton RA; Clarke BF; Duncan LJ
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1687-91. PubMed ID: 3924216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin.
    Wilinska ME; Chassin LJ; Schaller HC; Schaupp L; Pieber TR; Hovorka R
    IEEE Trans Biomed Eng; 2005 Jan; 52(1):3-12. PubMed ID: 15651559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of insulin absorption and blood flow during massage of a subcutaneous injection site.
    Linde B
    Diabetes Care; 1986; 9(6):570-4. PubMed ID: 3542450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.